Forty years of anti-D immunoprophylaxis

Blood Transfusion

Volumn 5, Issue 1, 2007, Pages 3-6

  Reali, Giorgio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA VACCINE; IMMUNOGLOBULIN M; RHESUS D ANTIBODY; TETANUS ANTIBODY;

AMNIOCENTESIS; ANEMIA; CHORION VILLUS; CORDOCENTESIS; DIPHTHERIA; DRUG INHIBITION; ECTOPIC PREGNANCY; EDITORIAL; FETOMATERNAL TRANSFUSION; FETUS DEATH; FETUS HYDROPS; HUMAN; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; NEWBORN JAUNDICE; PATHOGENESIS; SUPPRESSOR CELL; TETANUS; TWIN PREGNANCY;

EID: 47749112434     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2007.0b18-06     Document Type: Editorial

References (25)

1. Velati C. A survey of the current use of anti-D immunoprophylaxis and the incidence of haemolytic disease of the newborn in Italy. Blood Transfus 2007; 5; 7-14.
2. Levine P, Katzin EM, Burnham L. Isoimmunization in pregnancy, its possible bearing on the etiology of erythroblastosis fetalis. JAMA 1941; 116: 825-7.
3. Wallerstein H. Treatment of severe erythroblastosis by simultaneous removal and replacement of blood of the newborn. Science 1946; 103: 583-4.
4. Finn R. Report of a meeting at the Liverpool Medical Institution: February 18th 1960. Lancet 1960: i: 526.
5. Finn R, Clarke CA, Donohue WTA, et al. Experimental studies on the prevention of Rh haemolytic disease. Br Med J 1961; I: 1486-90.
6. Freda VJ, Gorman JG, Pollack W. Successful prevention of experimental Rh sensitisation in man with an anti-Rh gamma-2-globulin preparation: a preliminary report. Transfusion 1964; 4: 26-32.
7. Bowman JM. Hemolytic disease of the newborn. Vox Sang 1996; 70 (Suppl 3): 62-7.
8. Auden GA. A series of fatal cases of jaundice in the newborn occurring in successive pregnancies. St Barts Hosp Rep 1905; 41: 139-41.
9. Hubbard JC. An unusual obstetrical history. Boston Med Surg J 1913; 169: 459-60.
10. von Gierke E. Kernicterus und Erythroblastose. Verh Dtsch Ges Path 1921; 16: 322-4.
11. Diamond LK, Blackfan KD, Baty JM. Erythroblastosis fetalis and its association with universal edema of the fetus, icterus gravis neonatorum, and anemia of the newborn. J Pediatr 1932; 30: 269-309.
12. Darrow RR. Icterus gravis (erythroblastosis) neonatorum. An examination of etiologic considerations. Arch Pathol 1938; 25: 378-417.
13. Levine P, Stetson RE. An unusual case of intra-group agglutination. JAMA 1939; 113: 126-7.
14. Mollison PL, Walker W. Controlled trials of the treatment of haemolytic disease of the newborn. Lancet 1952; i: 429-33.
15. Woodrow JC, Donohoe WT. Rh-immunization by pregnancy: results of a survey and their relevance to prophylactic therapy. Br Med J 1968; iv: 159-44.
16. Sansone G. La malattia emolitica neonatale, ieri e oggi. In: Sansone G, Dambrosio F (editors). Atti del Convegno sui Problemi Attuali della MEN. Genoa, 17-19 December 1971. Genoa, Stringa Editore; 1971. p 17-26.
17. th ed., Bethesda, MD, AABB; 2002.
18. Tovey LA. Towards the conquest of Rh haemolytic disease: Britain's contribution and the role of serendipity. Transfus Med 1992; 2: 99-109.
19. Levine P. The influence of the ABO system on Rh hemolytic disease. Hum Biol 1958; 30: 14-28.
20. Clarke CA. Preventing Rhesus babies: the Liverpool research and follow up. Arch Dis Child 1989; 64: 1734-40.
21. de Silva M, Engelfriet CP, Reesink HW (editors). International Forum. Current status of immunoprophylaxis with anti-D immunoglobulins. Vox Sang 2003; 85: 328-37.
22. Martin-Vega C. Prevention of haemolytic disease of the newborn produced by immunisation to anti-D. In: Levene C, Blanchard D, Anstee DJ, editors, Red Cell Immunohaematology towards its Second Century: Old and New Methods in Transfusion Practice. Proceedings of the ESTM Residential Course, Tel Aviv 6th-9th May 1999, Milan: ESTM Ed; 1999. p. 183-5.
23. Kleihauer E, Braun H, Betke K. Demonstration von fetalem Hämoglobin in den Erythrozyten eines Blutausstrischs. Klin Wochenschr 1957; 35: 637-8.
24. Flegel WA, Wagner FF. Molecular biology of partial D and weak D: implications for blood bank practice [review]. J Clin Lab 2002; 48: 53-9.
25. Royal College of Physicians of Edinburgh and Royal College of Obstetricians and Gynaecologist of UK London [No Authors listed]. Statement from the Consensus Conference on anti-D prophylaxis. Vox Sang 1998; 74: 127-8.